Skip to main content
. 2013 Feb 21;8(3):252–267. doi: 10.4161/epi.23817

Table 2. Differentially hypomethylated genes between chromophobe RCC and renal oncocytoma samples.

Gene Symbol Cancer Target ID Relation to Gene CpG region Meth in Onco (B value < 0.25) Meth in Chromo (B value < 0.5) Normal Kidney Corrected P Value Chr
ITGB5
Oc
cg00171092
Body
Open Sea
7/21 (33.3%)
0/20 (0.0%)
0/4
2.73629E-08
3
GTF2IRD1; GTF2IRD1
Ch
cg20448594
Body; Body
Open Sea
0/21 (0.0%)
7/20 (35.0%)
0/4
2.9116E-08
7
PABPC4L
Ch
cg15867829
3′UTR
Open Sea
0/21 (0.0%)
9//20 (45.0%)
0/4
1.19954E-07
4
PRKCE
Ch
cg04035064
Body
Open Sea
0/21 (0.0%)
7/20 (35.0%)
0/4
2.96639E-07
2
CTDSPL; CTDSPL
Oc
cg15428496
Body; Body
Open Sea
7/21 (33.3%)
0/20 (0.0%)
0/4
3.0075E-07
3
PLCL1
Oc
cg02833180
Body
Open Sea
10/21 (47.6%)
0/20 (0.0%)
0/4
3.16345E-07
2
CD44; CD44; CD44; CD44; CD44
Ch
cg25096745
Body; Body; Body; Body; Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
3.33221E-07
11
TSPAN5
Oc
cg03234557
Body
Open Sea
9/21 (42.8%)
0/20 (0.0%)
0/4
8.95274E-07
4
SCG3; SCG3
Ch
cg08884979
3′UTR; 3′UTR
Open Sea
0/21 (0.0%)
11/20 (55.0%)
0/4
4.80724E-06
15
CSRP2BP; CSRP2BP
Ch
cg14329508
3′UTR; Body
Open Sea
0/21 (0.0%)
7/20 (35.0%)
0/4
1.54058E-05
20
MIR141
Ch
cg19794481
TSS200
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
1.58595E-05
12
SLC44A3; SLC44A3
Ch
cg22608160
Body; Body
Open Sea
0/21 (0.0%)
7/20 (35.0%)
0/4
3.38953E-05
1
MICAL2
Oc
cg00286773
Body
Open Sea
7/21 (33.3%)
0/20 (0.0%)
0/4
3.57384E-05
11
PHTF2; PHTF2
Ch
cg27457191
5′UTR; 5′UTR
S.Shore
0/21 (0.0%)
6/20 (30.%)
0/4
4.13981E-05
7
RORA
Ch
cg03952578
Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
4.68702E-05
15
ARID1B; ARID1B; ARID1B
Ch
cg04924555
Body; Body; Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
5.74559E-05
6
LRIG1
Ch
cg11198596
Body
N.Shelf
0/21 (0.0%)
6/20 (30.%)
0/4
5.78502E-05
3
COL18A1; COL18A1; COL18A1
Ch
cg25049844
3′UTR; 3′UTR; 3′UTR
S.Shore
0/21 (0.0%)
7/20 (35.0%)
0/4
9.73444E-05
21
ITPRIP
Ch
cg16301004
5′UTR
Open Sea
0/21 (0.0%)
7/20 (35.0%)
0/4
9.8974E-05
10
RAB3B
Ch
cg00714309
Body
Open Sea
0/21 (0.0%)
8/20 (40.0%)
0/4
0.0001
1
MIR141
Ch
cg02624246
Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0001
12
GBE1
Ch
cg05514531
Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0002
3
SLC27A3
Ch
cg15930240
Body
S.Shore
0/21 (0.0%)
6/20 (30.%)
0/4
0.0002
1
MKLN1; MKLN1
Ch
cg02776119
Body; Body
S.Shelf
0/21 (0.0%)
6/20 (30.%)
0/4
0.0002
7
C14orf169; HEATR4
Ch
cg02935494
TSS1500; Body
N.Shore
0/21 (0.0%)
9//20 (45.0%)
0/4
0.0002
14
VPS13B; VPS13B
Ch
cg18520777
Body; Body
Open Sea
0/21 (0.0%)
7/20 (35.0%)
0/4
0.0002
8
MYO3B; MYO3B; MYO3B
Ch
cg16066505
Body; Body; Body
Open Sea
0/21 (0.0%)
8/20 (40.0%)
0/4
0.0002
2
DSG1
Ch
cg07703790
TSS1500
Open Sea
0/21 (0.0%)
8/20 (40.0%)
0/4
0.0005
18
RNPEP
Ch
cg16047663
3′UTR
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0005
1
OR2B2
Ch
cg19173375
TSS200
Open Sea
0/21 (0.0%)
8/20 (40.0%)
0/4
0.0006
6
NEK11; NEK11; NEK11
Ch
cg06239593
Body; Body; Body
S.Shelf
0/21 (0.0%)
6/20 (30.%)
0/4
0.0009
3
NRP2; NRP2; NRP2; NRP2; NRP2
Ch
cg14157435
Body; Body; Body; Body; Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0012
2
PLEKHG7; PLEKHG7
Ch
cg05916700
1stExon; 5′UTR
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0021
12
CDKAL1
Ch
cg00682125
Body
Open Sea
0/21 (0.0%)
7/20 (35.0%)
0/4
0.0031
6
HOXC4; HOXC6; HOXC5
Ch
cg18040878
TSS1500; TSS1500; TSS1500
S.Shore
0/21 (0.0%)
6/20 (30.%)
0/4
0.0046
12
ACTN2
Ch
cg18381395
Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0050
1
C6orf195
Ch
cg01285783
Body
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0055
6
MGRN1; MGRN1; MGRN1; MGRN1
Ch
cg02074956
Body; Body; Body; Body
N.Shore
0/21 (0.0%)
6/20 (30.%)
0/4
0.0090
16
SVIL; SVIL
Ch
cg04678141
TSS200; 5′UTR
Open Sea
0/21 (0.0%)
6/20 (30.%)
0/4
0.0149
10
CAST; CAST; CAST; CAST; CAST
Ch
cg01741836
TSS1500; TSS1500; TSS1500; TSS1500; TSS1500
N.Shore
0/21 (0.0%)
6/20 (30.%)
0/4
0.0169
5
NDUFAF1
Ch
cg13897914
TSS1500
S.Shore
0/21 (0.0%)
6/20 (30.%)
0/4
0.0234
15
ACCN4; ACCN4 Ch cg08614334 Body; Body S.Shelf 0/21 (0.0%) 6/20 (30.%) 0/4 0.0275 2

Oc, renal oncocytoma; Ch, chromophobe RCC; Chr, chromosome.